Stem cell therapy for cirrhosis may be effective, but it is still in the stage of theoretical research and clinical trials. Stem cells include umbilical cord blood stem cells, autologous bone marrow stem cells, and autologous peripheral stem cells, which can be infused with structurally and functionally normal cells to patients through various therapeutic routes, such as peripheral veins and femoral arteries, theoretically repairing the damaged liver tissues and improving liver function. Stem cells can differentiate into functional hepatocytes with certain anti-inflammatory and paracrine effects to improve liver function. Stem cells may help reduce symptoms such as fatigue, bloating, loss of appetite, and ascites in patients with cirrhosis. There are still some problems with stem cell therapy for cirrhosis, which is in the stage of basic and clinical trials, and its effect needs to be confirmed by more clinical studies.